[1]田青,李景攀.加减补肺汤联合沙美特罗对慢性阻塞性肺疾病患者肺功能的影响[J].西部中医药,2020,33(07):107-110.[doi:10.12174/j.issn.1004-6852.2020.07.28]
　TIAN Qing,LI Jingpan.Effects of Modified Bufei Tang and Salmeterol on Pulmonary Function of COPD Patients[J].Western Journal of Traditional Chinese Medicine,2020,33(07):107-110.[doi:10.12174/j.issn.1004-6852.2020.07.28]
点击复制

加减补肺汤联合沙美特罗对慢性阻塞性肺疾病患者肺功能的影响
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
33
期数:
2020年07期
页码:
107-110
栏目:
出版日期:
2020-07-15

文章信息/Info

Title:
Effects of Modified Bufei Tang and Salmeterol on Pulmonary Function of COPD Patients
文章编号:
1004-6852(2020)07-0107-04
作者:
田青，李景攀
成都市第一人民医院呼吸内科，四川 成都 610000
Author(s):
TIAN Qing, LI Jingpan
Department of Respiratory Medicine, Chengdu First People′s Hospital, Chengdu 610000, China
关键词:
慢性阻塞性肺疾病; 呼吸指数; 氧合指数; 动脉-肺泡氧气分率; 加减补肺汤; 沙美特罗; 中西医结合
Keywords:
COPD;  RI;  OI;  M index;  modified Bufei Tang;  salmeterol;  integrative medicine
分类号:
R563
DOI:
10.12174/j.issn.1004-6852.2020.07.28
文献标志码:
B
摘要:
目的：探讨加减补肺汤联合沙美特罗治疗慢性阻塞性肺疾病(chronic obstructive pulmonary disease，COPD)的效果及对患者呼吸指数(respiratory index，RI)、氧合指数(oxygenation index，OI)和动脉-肺泡氧气分率(M指数)的影响。方法：将COPD患者90例采用随机数字表法分为对照组和研究组各45例，对照组采用沙美特罗治疗，研究组采用加减补肺汤联合沙美特罗治疗。观察两组患者疗效、肿瘤坏死因子α(tumor necrosis factor α，TNF-α)和白细胞介素8(interleukin-8，IL-8)水平以及RI、OI和M指数改善情况。结果：治疗后研究组患者第一秒用力呼气容积(first second forced expiratory volume，FEV1)、FEV1%、6 min步行试验(6-minute walk test，6MWT)以及第一秒呼气容积同肺活量(forced vital capacity，FVC)之间的比值(FEV1/FVC)均高于对照组(P＜0.05)；两组患者TNF-α、IL-8低于对照组(P＜0.05)；治疗后研究组患者RI和M指数低于对照组，OI高于对照组(P＜0.05)；有效率研究组为93.4%(42/45)，对照组为71.2%(32/45)，两组比较差异具有统计学意义(P＜0.05)。结论：加减补肺汤联合沙美特罗可以改善COPD患者肺功能，降低血清炎性因子水平，对提高治疗效果以及改善RI、OI和M指数有积极意义。
Abstract:
Objective: To discuss clinical effects of modified Bufei Tang and salmeterol in the treatment of COPD and its influence on RI, OI and M index. Methods: All 90 COPD patients were randomized into the control group and the study group according to random number table method, 45 cases each group, the control group adopted salmeterol, and the study group modified Bufei Tang and salmeterol. To observe clinical effects of both groups, the levels of TNF-α and IL-8, and the improvements of RI, OI and M index. Results: After treating, FEV1, FEV1%, 6MWT and FEV1/FVC of the study group were higher than these of the control group(P＜0.05); the levels of TNF-α and IL-8 were lower than these of the control group(P＜0.05); after treating, RI and M index of the study group were lower than these of the control group, OI higher than that of the control group(P＜0.05); the effective rate of the study group was 93.4%(42/45), higher than 71.2%(32/45) of the control group, and the difference had statistical meaning (P＜0.05). Conclusion: Modified Bufei Tang and salmeterol could help improve pulmonary function, relieve the influence of serum inflammatory factors, and it is positive to raise therapeutic effects and improve RI, OI and M index.

相似文献/References:

[1]王萍.慢性阻塞性肺病患者实施临床护理路径的疗效分析[J].西部中医药,2014,27(11):140.
[2]王 燕,孙凤英,倪 军.慢性阻塞性肺疾病患者非药物治疗依从性与生活质量相关性的研究[J].西部中医药,2015,28(03):89.
[3]郭晓燕,尹广超,陆城华,等.川芎平喘合剂对COPD患者血管内皮功能的调节作用[J].西部中医药,2015,28(05):1.
[4]王振伟,杨佩兰,沈丽,等.百部养肺煎膏治疗COPD稳定期患者的临床研究[J].西部中医药,2015,28(05):56.
[5]赵宇冰,林丽明.老年慢性阻塞性肺疾病患者缓解期的社区康复治疗[J].西部中医药,2012,25(08):59.
　ZHAO Yu-bing,LIN Li-ming.Community Rehabilitation Therapy for Senile Patients with COPD at Remission Stage[J].Western Journal of Traditional Chinese Medicine,2012,25(07):59.
[6]张旭辉,杨虹.咳喘宁胶囊治疗稳定期慢性阻塞性肺疾病的疗效评价[J].西部中医药,2016,29(03):1.
　ZHANG Xuhui,YANG Hong.Evaluation of Clinical Effects of KeChuanNing Capsules in Treating Chronic Obstructive Pulmonary Disease at Stable Stage[J].Western Journal of Traditional Chinese Medicine,2016,29(07):1.
[7]晏燕,孙建勤,姜冰玉,等.中西医结合治疗老年慢性阻塞性肺疾病急性加重期的临床疗效[J].西部中医药,2016,29(07):96.
　YAN Yan,SUN Jianqin,JIANG Bingyu,et al.Clinical Effects of Integrative Medicine in Treating Chronic Obstructive Pulmonary Disease of Senile Patients at Acute Exacerbation[J].Western Journal of Traditional Chinese Medicine,2016,29(07):96.
[8]施巍,苟小军,王道才,等.刺络放血法治疗慢性阻塞性肺疾病急性加重期48例[J].西部中医药,2017,30(02):96.
　SHI Wei,GOU Xiaojun,WANG Daocai,et al.Blood-letting Therapy in Treating 48 Cases of Chronic Obstructive Pulmonary Disease at Acute Exacerbation Stage[J].Western Journal of Traditional Chinese Medicine,2017,30(07):96.
[9]郭晓燕,腾飞,张惠勇.川芎平喘合剂治疗慢性阻塞性肺疾病的随机对照研究[J].西部中医药,2018,31(01):1.
　GUO Xiaoyan,TENG Fei,ZHANG Huiyong.A Randomized, Controlled Study of ChuanXiong PingChuan Mixture in Treating Chronic Obstructive Pulmonary Disease[J].Western Journal of Traditional Chinese Medicine,2018,31(07):1.
[10]史素丽,尚秀娟△,曹凤英.老年慢性阻塞性肺疾病患者主观幸福度及影响因素分析[J].西部中医药,2016,29(01):93.
　SHI Suli,SHANG Xiujuan,CAO Fengying.Analysis of Influencing Factors and Subjective Happiness Index of Senile Patients with Chronic Obstructive Pulmonary Disease[J].Western Journal of Traditional Chinese Medicine,2016,29(07):93.

备注/Memo

备注/Memo:
收稿日期：2019-02-21*基金项目：四川省第一批省级科技计划项目(2014SZ0010)。作者简介：田青(1968—)，女，副主任医师。研究方向：慢性阻塞性肺疾病、支气管哮喘的诊治。
更新日期/Last Update: 2020-07-15